Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocardial Perfusion and Fibrosis in HFpEF
NCT02589977Phase 4Completed
- Start
- Nov 2015
- Primary completion
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of regadenoson in heart failure with preserved ejection fraction (HFpEF). Started Nov 2015; status: completed.
02
Drugs
regadenoson
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT02589977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02589977.